LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today
Learn More About ConcentRx
ConcentRx
image
ConcentRx is a preclinical stage company with a patented Immunotherapy developed for Ovarian, Breast and Lymphoma. Outside of the body we activate a patient's or a donor's white cells with a proprietary and specific activation protocol to induce enrichment and selection of NK-T cells home to and target selectively tumor cells. Prior to infusion into the patient the NK-T cells are allowed to take up a tumor lysis agent for selective killing of the tumor cells. In preclinical animal models of disease our therapy is active against chemo therapy resistant cells of multiple tumor types and reduces the recurrence of disease.
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
CEO presentation
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next